Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic

Mubashir Hassan1, Sara Zahid2, Hany Alashwal3

  • 1Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. mubashirhassan_gcul@yahoo.com.

Scientific Reports
|June 11, 2021
PubMed

Insights

Researchers identified key interactions between TNFR1 and MADD proteins, revealing specific amino acid residues involved in neuronal cell death pathways relevant to Alzheimer's disease. Targeting these interactions offers a potential therapeutic strategy for Alzheimer's disease.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Computational Biology

Background:

  • Tumor Necrosis Factor Receptor 1 (TNFR1) and MADD proteins interact to mediate signaling pathways.
  • These interactions are implicated in neuronal cell death and the pathogenesis of Alzheimer's disease.

Purpose of the Study:

  • To investigate the interactive behavior of TNFR1 and MADD proteins using molecular docking.
  • To explore their role in activating downstream signaling pathways linked to Alzheimer's disease.

Main Methods:

  • Molecular docking simulations were used to analyze TNFR1-MADD protein interactions.
  • Molecular dynamic simulations were performed to assess the stability of binding interactions between death domains.

Main Results:

  • Identified common residues (Asp400, Arg58, Arg59) in TNFR1 and MADD crucial for activating downstream signaling.
  • Confirmed the stability of TNFR1 and MADD death domains during binding interactions.
  • Observed conformational changes in TNFR1 upon MADD interaction, activating mediator proteins.

Conclusions:

  • Understanding TNFR1 and MADD interactions provides insights into Alzheimer's disease mechanisms.
  • The death domains of TNFR1 and MADD represent a potential pharmacological target for Alzheimer's disease treatment.
  • Inhibiting the MAPK pathway via targeting these death domains may offer a therapeutic avenue.